Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas.

Treatment with miransertib alone reduced tumor growth but did not reach statistical significance despite a significant reduction in the levels of pAkt ( Figure 4I ).

also in 111,027 other papers